Insights
HTA in Japan: Failing to Meet International Good Practice?
15 March 2019
The Japanese government has recently announced new plans to implement HTA from April 2019. The ISPOR HTA Task Force published ‘Good Practices in HTA’ in January…
As UN General Assembly Highlights Tuberculosis Fight, Will BRICS Lead on the R&D Agenda?
26 September 2018
The Center for Global Development and the Office of Health Economics are working on a new approach to drive the next generation of investment for better…
MoCA Initiative and its Value Framework: An Opportunity to Improve Decision Making for Orphan Drugs in Europe?
18 September 2018
Orphan drugs inherently face a number of challenges in their development and value assessment. In this blog post, we describe the Mechanism of Coordinated Action (MoCA)…
NICE Recommendation Highlights Role of Social Value Judgements
9 August 2018
This blog post discusses the role of social value judgements in NICE technology appraisals, focusing on the recent appraisal of dinutuximab beta for high-risk neuroblastoma. The…
Alan Maynard – Alas No More
5 February 2018
Tony Culyer writes on the contribution to health economics of Alan Maynard, the pioneering health economist, who died on February 2nd 2018. If you wanted to…
The Long-term Sustainability of the NHS and Adult Social Care
13 April 2017
On 5th April 2017 the House of Lords Select Committee on the Long-term Sustainability of the NHS published their report titled “The Long-term Sustainability of the…
5 Things You Should Do with EQ-5D Data
29 January 2016
Professor Nancy Devlin outlines her top 5 recommendations for anyone collecting or reporting EQ-5D data. Written by Professor Nancy Devlin, Director of Research at OHE and…
Using Competition with Care: Comment on the Revised Regulations for the NHS
19 March 2013
OHE’s Jon Sussex has studied and written extensively on competition in the NHS. He was a member of the OHE Commission on Competition in the NHS…